Special shake may tame Immunotherapy's worst side effects in melanoma patients
NCT ID NCT06880198
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tests whether a special nutritional drink called Oral Impact can reduce severe side effects from immunotherapy in 20 people with advanced melanoma that cannot be surgically removed. Participants take the drink starting one week before their standard immunotherapy treatment. The goal is to see if this approach lowers the frequency and severity of immune-related side effects compared to similar patients from past studies who did not receive the drink.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale"
RECRUITINGNaples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.